Research

We are keen on designing and building artificial mimics of natural cells using minimal components, with emphasis on creating out-of-equilibrium conditions. The scope for such an endeavour encompasses both the entities made from and incorporating natural and synthetic components, as well as entities without clearcut biological analogues. A basic starting point for creating synthetic cells is a three-dimensional microcontainer, that separates the self from the surrounding environment. To regulate the thousands of interconnected biochemical reactions, cells have developed various strategies for compartmentalization of their cytoplasm. A relatively recent finding is that of membraneless organelles or biomolecular condensates. Our exploration here is two-fold: (i) To bioengineer membranous vesicles, regulate its morphology, and ultimately make it an active motile system capable of responding to external cues. (ii) Study condensate dynamics within membranous vesicles and carry out distinct biochemical reactions in each of these condensates, thus making rudimentary bioreactors.

We are also using the synthetic cell platform to study the fundamentals of biological systems, especially with regards to the self-assembly of proteins. We are focusing on two processes: (i) studying the actin cytoskeleton that drives shape changes to the cell, and (ii) protein-based condensates that are involved the cytoskeletal functionality as well as potential novel and yet unknown functions. The role of condensates in cytoskeletal functionality and cell shaping is highly unexplored, and we are studying the interplay of condensates and actin dynamics within cell-mimicking vesicles using state-of-the-art microfluidic systems. We frequently collaborate with experts, for example, with Dolf Weijers (WUR) to explore the self-assembly behavior of plant polarity proteins and with Ingrid Dijkgraaf (Maastricht University) to understand the biomechanics of condensate-forming proteins from tick saliva.

Rapid diagnosis is key to ensuring optimized treatment of diseases. Biosensing techniques, however, can be quite slow to perform, often requiring specialized laboratory equipment or technicians to interpret. We want to probe the potential of liquid crystals to exhibit a clear and rapid optical response in presence of biomarkers (antibodies, toxins, etc.). By harnessing their unique ability to exhibit crystalline ordering and birefringence, our goal is to produce a liquid crystal-based biosensor capable of rapid in situ detection of biomolecules. We would ultimately like to prototype a lab-on-a-chip diagnostic test that can be used on-field by a non-expert.

Microfluidic technology offers experimentalists highly controllable and versatile environments. A typical lab-on-a-chip device handles small fluid volumes (in the µL range), flowing through very well-defined channels (of µm dimensions) at low enough flow rates (µL/min or much less). Such setting ensures laminar flow, offering innovative and unique possibilities to control molecules in space and time. Over the years, we have developed numerous microfluidic assays to tackle biological questions: quasi-2D microchambers to study step-by-step biopolymer reactions in a flow-free manner, flow-assays to understand the surface-sensing mechanism in bacteria, physical chemistry-based bubble-blowing machines for making cell-mimicking vesicles, etc. We extensively utilize our on-chip tools, develop them further, and seek to design new ones.